Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Innao

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Annals of Hematology|December 20, 2019
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplantMassimo Martino, Mercedes Gori, Giovanni Tripepi, et al.
European Journal of Haematology|April 24, 2026
Regional Standardization of CLL Management: Results of a Delphi Consensus ProcessEnrica Antonia Martino, Annalisa Chiarenza, Salvatrice Mancuso, et al.
British Journal of Haematology|July 3, 2026
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experienceAndrea Duminuco, Dario Leotta, Alessandro Allegra, et al.
Cancers|November 8, 2019
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled AnalysisFrancesca Bonello, Stefano Pulini, Stelvio Ballanti, et al.
European Journal of Haematology|September 25, 2023
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significanceGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
Haematologica|June 29, 2019
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trialsAlessandra Larocca, Roberto Mina, Massimo Offidani, et al.
Journal of Clinical Medicine|June 29, 2019
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma NetworkConcetta Conticello, Alessandra Romano, Vittorio Del Fabro, et al.
European Journal of Haematology|July 20, 2024
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET surveyBruno Fattizzo, Valentina Carrai, Monica Crugnola, et al.
British Journal of Haematology|August 26, 2025
Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 studyElisa Lucchini, Nicola Vianelli, Ugo Consoli, et al.
Blood Advances|April 16, 2025
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohortAndrea Serafin, Alessandro Cellini, Enrica Antonia Martino, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Annals of Hematology|December 20, 2019
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplantMassimo Martino, Mercedes Gori, Giovanni Tripepi, et al.
European Journal of Haematology|April 24, 2026
Regional Standardization of CLL Management: Results of a Delphi Consensus ProcessEnrica Antonia Martino, Annalisa Chiarenza, Salvatrice Mancuso, et al.
British Journal of Haematology|July 3, 2026
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experienceAndrea Duminuco, Dario Leotta, Alessandro Allegra, et al.
Cancers|November 8, 2019
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled AnalysisFrancesca Bonello, Stefano Pulini, Stelvio Ballanti, et al.
European Journal of Haematology|September 25, 2023
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significanceGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
Haematologica|June 29, 2019
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trialsAlessandra Larocca, Roberto Mina, Massimo Offidani, et al.
Journal of Clinical Medicine|June 29, 2019
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma NetworkConcetta Conticello, Alessandra Romano, Vittorio Del Fabro, et al.
European Journal of Haematology|July 20, 2024
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET surveyBruno Fattizzo, Valentina Carrai, Monica Crugnola, et al.
British Journal of Haematology|August 26, 2025
Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 studyElisa Lucchini, Nicola Vianelli, Ugo Consoli, et al.
Blood Advances|April 16, 2025
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohortAndrea Serafin, Alessandro Cellini, Enrica Antonia Martino, et al.
Pageof 7